Gratus Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$725K Hold
2,853
0.09% 75
2026
Q1
$697K Buy
2,853
+215
+8% +$50.1K 0.1% 72
2025
Q4
$546K Sell
2,638
-230
-8% -$45.5K 0.08% 84
2025
Q3
$532K Sell
2,868
-154
-5% -$26.4K 0.07% 94
2025
Q2
$462K Sell
3,022
-213
-7% -$32.7K 0.07% 96
2025
Q1
$536K Sell
3,235
-26
-0.8% -$4.07K 0.09% 90
2024
Q4
$472K Sell
3,261
-872
-21% -$135K 0.08% 91
2024
Q3
$659K Sell
4,133
-239
-5% -$38.1K 0.11% 81
2024
Q2
$676K Sell
4,372
-1,856
-30% -$276K 0.12% 81
2024
Q1
$908K Sell
6,228
-100
-2% -$15.9K 0.17% 58
2023
Q4
$992K Buy
+6,328
New +$970K 0.2% 54

Other funds holding JNJ

Gratus Wealth Advisors's JNJ Position: Q2 2026 in Review

Gratus Wealth Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 2,853 shares worth $725K. The position accounts for 0.09% of the portfolio, ranked #75.

Gratus Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $992K in Q4 2023. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gratus Wealth Advisors held 2,853 shares of Johnson & Johnson worth $725K as of Q2 2026.
  • Gratus Wealth Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.09% of Gratus Wealth Advisors's portfolio in Q2 2026, its #75 holding.
  • Gratus Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Gratus Wealth Advisors's Johnson & Johnson position peaked at $992K in Q4 2023.
  • 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gratus Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.